Neo-Tetrapro 200 mg Powder For Solution is a Health Canada–registered veterinary drug (DIN 02530368) held by Can-Vet Animal Health Supplies Ltd., containing Tetracycline Hydrochloride. Health Canada lists its status as Marketed (status date 27 Sep 2022). Nexara Health has matched 222 registrations of Tetracycline Hydrochloride across 24 other regulated markets.

Health Canada registration

Tetracycline Hydrochloride registered in other markets

222 registrations of the same molecule in 24 national registries outside Canada (first 87 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Tetracycline Hydrochloride worldwide →

Regulator price references for Tetracycline Hydrochloride

Published list or reimbursement prices for Tetracycline Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Neo-Tetrapro (DIN 02530368) marketed in Canada?

Yes. Health Canada lists DIN 02530368 as Marketed as of 27 Sep 2022.

Who holds the Canadian licence for this product?

Can-Vet Animal Health Supplies Ltd. is the company of record in the Health Canada Drug Product Database.

Is Tetracycline Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 222 registrations in 24 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02530368, status date 2022-09-27; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, PAMI, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02530368, status date 2022-09-27; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, PAMI, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 02530368, status date 2022-09-27; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, PAMI, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.